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Functional xenobiotic metabolism and eﬄux
transporters in trout hepatocyte spheroid cultures
Chibuzor Uchea,a,b Stewart F. Owen*b and J. Kevin Chipmana
Prediction of xenobiotic fate in ﬁsh is important for the regulatory assessment of chemicals under current
legislation. Trout hepatocyte spheroids are a promising in vitro model for this assessment. In this investi-
gation, the gene expression and function for xenobiotic metabolism and cellular eﬄux were character-
ised. Using ﬂuorescence, transport and real time PCR analysis, the expression and functionality of a variety
of genes related to xenobiotic metabolism and drug eﬄux were assessed in a range of trout hepatocyte
culture preparations. Signiﬁcantly greater levels of expression of genes involved in xenobiotic metabolism
and eﬄux were measured in spheroids (which have been shown to remain viable in excess of 30 days),
compared to hepatocytes cultured using conventional suspension and monolayer culture techniques.
A transient decline in the expression of genes related to both xenobiotic metabolism and transport was
determined during spheroid development, with a subsequent recovery in older spheroids. The most
mature spheroids also exhibited an expression proﬁle most comparable to that reported in vivo. Functio-
nality of eﬄux transporters in spheroids was also demonstrated using ﬂuorescent markers and speciﬁc
inhibitors. In conclusion, the more physiologically relevant architecture in spheroid cultures provides a
high functional integrity in relation to xenobiotic metabolism and eﬄux. Together with the enhanced
gene expression and longevity of the model, hepatocytes in spheroid culture may prove to be an accurate
alternative model to study the mechanisms of these processes in ﬁsh liver and provide an assay to deter-
mine the bioaccumulation potential of environmental contaminants.
Introduction
Recently, there has been a significant focus on the benefits of
3D cell cultures, shown to provide an in vitro model system cir-
cumventing the major limitations (short lived nature and loss
of diﬀerentiation with time) of traditional monolayer primary
cell cultures, maintaining cellular specificity and
homeostasis.1–5 The environment created within 3D cultures
involving hepatocytes appears more representative of that in
which cells exist in native liver. Hepatocytes are surrounded by
other interacting cells, maintaining cell shape and polarity.
Together with the development of a more elaborate extracellu-
lar matrix, these are features necessary for many specialised
functions and potentially responsible for the conserved diﬀer-
entiation status and longevity in spheroids.6–8 The mainten-
ance of polarity in hepatocyte spheroid culture is also thought
to have a key role in the re-formation of bile canaliculi in the
system.6 Vast diﬀerences in the cellular responses of hepato-
cyte spheroids to chemical exposure have also been described
compared to those of conventional cultures. For example,
higher resistance to anticancer drugs in 3D tumour cell spher-
oids in comparison to the same cells in 2D culture has been
reported.9 The toxic potential of cadmium and silver nanopar-
ticles has also been reported to be significantly reduced in
spheroid culture of HepG2 cells when compared to data
obtained from conventional cell culture.10 These cell responses
in spheroid culture are thought to be more reflective of those
exhibited in vivo, enhancing the predictive power of in vitro
toxicity testing and use of the system in drug screening has
been promoted.3,11,12 Indeed, spheroids are now routinely
used as in vitro models in cancer and pharmaceutical testing.9
Based on their enhanced cytochrome P450 (CYP) activity
towards ethoxyresorufin, the potential for 3D spheroid aggre-
gates of trout hepatocytes to be used as a superior in vitro
alternative to currently used subcellular fractions and mono-
layer cultures in studies of the metabolism and bioaccumula-
tion of environmental compounds in aquatic organisms has
recently been demonstrated.13 Alongside these findings, trout
hepatocyte spheroids have been shown to outperform 2D cul-
tures biochemically, with significantly enhanced glucose pro-
duction and albumin synthesis and reduced lactate
dehydrogenase leakage.14 These studies have also reported the
potential benefits of extended longevity (spheroids have been
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maintained viable and active for over 30 days in our labora-
tories) conferred by 3D cultures in chronic exposure
assessments.
The maintenance of drug metabolism capabilities in spher-
oids is likely due to well retained gene expression and studies
using human hepatocyte spheroid cultures have demonstrated
the stable expression of membrane transporters and enzymes
related to drug metabolism.15 This may arise from the
enhanced inter-cellular connectivity of cells and the extended
stabilisation period aﬀorded to hepatocytes in this culture
form, during which, metabolic activity, levels of gene
expression and other features influencing cellular phenotype
can be recovered following the cell isolation process.5,16 Rat
hepatocyte spheroids have been reported to undergo an initial
period of biochemical and functional turbulence as they
mature in early culture and after about 6 days, functional
status is said to recover and stabilise.17
Another advantage of the use of hepatocytes in spheroid
culture for the assessment of bioaccumulation of xenobiotics
is the potential incorporation of measurements of transporter
function in these preparations. As with the enhanced meta-
bolic performance of hepatocyte spheroids,13 we hypothesised
that the functional activity of eﬄux transporters may also be
superior in 3D cultures. Proteins of the ATP binding cassette
(ABC) facilitate the excretory function in organisms, transport-
ing exogenous and endogenous compounds and/or their
metabolites out of cells.18 ABC proteins are heavily expressed
in the liver, which is a major site for compound elimination.
In recent years, greater recognition of the role of hepatic
transporters on the disposition and elimination of com-
pounds, and how these features combine with the metabolic
aspects of hepatic clearance, has led to the development of
eﬀective methods to accurately assess substrate specificity and
aﬃnity for eﬄux transporters.19,20 Conventional measure-
ments of hepatic clearance using subcellular fractions, as con-
ducted in environmental bioaccumulation assessment, must
assume the cellular uptake of compounds and eﬃcient eﬄux
activity of hepatic transporters. These processes which directly
aﬀect bioaccumulation are compound- and species-specific
and cannot be assessed using subcellular fractions alone.
Enhanced xenobiotic capabilities have been reported in
hepatocyte spheroids isolated from mammalian species. Main-
tenance of ethoxyresorufin-O-deethylation (EROD) activity and
the expression of a range of genes important to hepatocyte
function in rat hepatocyte spheroids have been demon-
strated.21,22 An enhanced level of UDP-glucuronosyltransferase
(UGT), CYP1A2, CYP2E1 and CYP3A4 activities, as well as
Multidrug resistance associated protein 2 (MRP2) expression
in a range of hepatocyte cell lines cultured as spheroids com-
pared to those of cells in 2D culture have also been
measured.23–25 Not only are these activities greater in compari-
son to conventional cultures, but they are also maintained for
extensive periods with viability in spheroid culture.4
In contrast, very few studies on the use of fish hepatocytes
in spheroid culture exist in the literature.14,26,27 The limited
information on trout hepatocytes in spheroid culture includes
evidence that vitellogenin mRNA expression and secretion is
maintained for up to a month in culture and the system has
been shown to be responsive to the eﬀects of classical modu-
lators of gene expression.26
In fish, as in mammals, proteins of the ABC superfamily
play a critical role in the transport of compounds and meta-
bolites into bile.28–30 This process results in the reduced intra-
cellular concentration and lower toxic potential of compounds,
as well as a reduced potential for bioaccumulation.31,32 ABC
transporters are membrane bound proteins consisting of two
transmembrane domains, which confer substrate specificity
and form the transmembrane channel, and two nucleotide
binding domains, which bind and hydrolyse ATP, resulting in
the active transport of a wide range of substrates from the cyto-
plasm and out of cells.33–35 These proteins are highly con-
served and are expressed in a wide range of cell types of all
known existing species, suggesting similar, fundamental physio-
logical roles.36,37 However, despite the physiological importance
of the process in fish, relatively little is known about the func-
tion and expression of eﬄux transporters in comparison to
their mammalian counterparts,38 ABC transporter subtypes are
highly expressed in tissues that make up internal and external
body boundaries and those involved in excretion, such as liver,
intestine and kidney tissue.38 These proteins are termed multi
drug resistance proteins (MDR) for their role in protecting
tumour cells from a wide range of structurally unrelated
chemotherapeutics.18,39,40 The diversity of the substrates that
proteins of the ABC transporter subfamily can export from
cells (including metabolic products of xenobiotic compounds,
as well as the parent and some endogenous compounds) is a
key feature of their biological importance.
Human ABC proteins are separated into seven subfamilies
(A–G) based on their sequence homology.41,42 In fish, an
additional subfamily (H), with one member has also been
identified.34 The most toxicologically relevant transporters in
mammalian species have been identified as the multidrug
resistance protein (MDR1, ABCB1), bile salt export pump
(BSEP, ABCB11), multidrug resistance-associated proteins 1–3
(MRP1-3, ABCC1-3) and breast cancer resistance protein
(BCRP, ABCG2).19,43 Recent publications have shown that a
variety of toxicologically relevant ABC eﬄux transporters are
expressed in trout, with a wide tissue distribution
pattern.29,34,44 MDR1, MRP2, BSEP and BCRP have been identi-
fied as the eﬄux transporters with the highest levels of
expression in trout liver.29,34,44–46
These transporters can be susceptible to inhibition by a
number of compounds, aﬀecting their ability to eliminate
xenobiotics and resulting in the intracellular accumulation of
compounds and possible toxic eﬀects. This is a key issue in
aquatic toxicology as a wide range of environmental contami-
nants are specific inhibitors of ABC transporters and so can
increase the sensitivity of organisms to further chemical
insult; especially important in the aquatic environment due to
the eﬀects of the vast mixtures of chemicals to which orga-
nisms are exposed.29,47–50 These interactions will also aﬀect
the bioaccumulation potential of compounds, due to potential
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reductions in clearance eﬃciency. Despite this knowledge,
there is very little information on the retention of such trans-
porter systems in fish hepatocyte spheroids and indeed little
in spheroids of any species.
Here we test the hypothesis that drug eﬄux transporters
were functionally active and expressed to a greater extent in
trout hepatocyte spheroids when compared to conventional
suspension and monolayer cultures and related to expression
in whole liver tissue. This may support the inclusion of assess-
ments of compound elimination from hepatocyte spheroids,
providing a more accurate comparison to in vivo hepatic clear-
ance and enhancing the utilisation of in vitro alternatives in
chemical safety assessment. To enable their use in such
assessments, the system must also be metabolically compe-
tent. Therefore the possibility that enhanced xenobiotic meta-
bolism is related to enhanced expression of relevant genes
associated with maintenance of the diﬀerentiation status in
spheroids was tested. The expression of genes related to xeno-
biotic metabolism and transport was measured during spher-
oid maturation and compared to freshly isolated hepatocytes
and in monolayer culture.
Materials and methods
Fish and maintenance
Female, diploid immature rainbow trout (Oncorhynchus
mykiss), with a wet weight range between 300 g–500 g were
held for a minimum 15 day acclimation period at the Univer-
sity of Birmingham prior to first use and fed floating proprie-
tary pellets (GP Pellets, Cheshire, UK), daily. These stock fish
were held with permission from the UK Home Oﬃce under
the Animals (Scientific Procedures) Act 1986 and therefore
under authorisation by the University Ethics Committee. The
aquaculture conditions were 15 ± 1 °C; 12L:12D photoperiod;
non re-circulated water at pH 7.5, hardness >150 mg l−1 CaCO3
and >80% oxygen saturation. Trout were fasted for 24 hours
prior to use. Fish were euthanised following the Schedule I pro-
tocol of the Animals (Scientific Procedures) Act 1986 – rendered
unconscious by a sharp blow to the head, with subsequent
destruction of the brain via pithing; following which they were
dissected to allow access to the liver. This study complied with
regulatory and ethical standards in the UK and the global
ethical standards required by the industrial partner AstraZeneca.
Isolation and culture of hepatocytes
Hepatocytes were isolated using a modified version of the col-
lagenase perfusion technique51 in which trout livers were per-
fused in situ through the hepatic portal vein at a flow rate of
2 ml min−1, firstly with calcium-free Hanks’ balanced salt solu-
tion (Sigma-Aldrich, Poole, UK) for approximately 20 minutes
and then with a dissociating solution containing 6.7 mM
CaCl2, 3.15 mM KCl, 0.3 mM Na2HPO4, 11.76 mM HEPES,
160 mM NaCl and 260 mg l−1 collagenase D (Roche Applied
Science, 11088858001) for approximately 15 minutes. A final
perfusion with Dulbecco’s Modified Eagle’s Medium/nutrient
mixture F-12 Ham supplemented with L-glutamine, 15 mM
HEPES (DMEM [Sigma-Aldrich]) was then provided for approxi-
mately 5 minutes to clear the collagenase from the liver. All
solutions were pre-incubated at 15 °C. Once digested, livers
were removed and cells were isolated from the organ mechani-
cally into DMEM and passed through a 100 μm nylon cell strai-
ner (BD falcon, Massachusetts, USA). Cells were washed 3 times
in DMEM following 3 periods of centrifugation (30g, 5 minutes,
15 °C) and viability (consistently ≥95%) was measured based on
exclusion of 0.04% trypan blue. Isolated primary hepatocytes
were plated at a density of 1 × 106 cells cm−2 on 24-well collagen
type I coated microplates (Iwaki, Japan) and stored in a 15 °C
stationary incubator. Hepatocytes in suspension were purified
to 1 × 106 cells ml−1 in centrifuge tubes, transferred to 50 ml
conical flasks and kept in a 15 °C shaking incubator at 90 rpm
(Infors-HT, Bottmingen, Switzerland).
Hepatocyte spheroid culture
Hepatocyte spheroids were prepared using a method pre-
viously described in our laboratory which yielded viable spher-
oids that were able to be maintained in excess of 30 days.13
Cells isolated following hepatocyte purification were re-sus-
pended in DMEM which was additionally supplemented with
serum replacement 3 (20 ml L−1) (Sigma-Aldrich) and an anti-
biotic/antimycotic solution (10 ml L−1) (Sigma-Aldrich,
MFCD00130520) at a concentration of 5 × 106 cells ml−1. Cell
suspensions (5 ml) were plated in sterile, non-treated 50 ×
18 mm petri dishes (Sterilin, Newport, UK) and placed on a
gyratory shaker (Stuart Scientific, Stone, UK) to aggregate at 50
rpm and 17 °C ± 1 °C. Cell culture medium was changed every
2 days and spheroids were used for gene expression analysis at
a range of time points. During spheroid formation, hepato-
cytes merge together, forming loose cellular aggregates which
later develop into larger, variable, asymmetrical clusters.
Between days 5–7 post isolation, structures became more
uniform in shape, with larger diameters and by day 8, little to
no change in their morphological arrangements when com-
pared to earlier time points is evident. At this stage, spheroids
in this study exhibited a more homogeneous shape with indi-
vidual cells no longer clearly visible; a feature considered as a
marker of morphological maturity. In this study, day 10 was
selected as the first time-point of maturity, to ensure that the
morphological maturation process was complete. A number of
reports in the literature suggest the optimal diameter for mam-
malian spheroids in the region of 100–150 µm to allow
eﬀective diﬀusion of oxygen, ensuring that the inner core
environment does not become hypoxic.9,52,53 Size analysis of
spheroid preparations using flow cytometry showed that the
spheroids used in this study ranged from 90–110 µm).
RNA extraction
Whole liver sections (100 mg) excised during the hepatocyte
isolation process, freshly isolated hepatocytes, hepatocytes in
monolayer culture and spheroids at a range of time points
were collected, washed with PBS (cells) and stored in RNA later
(Sigma-Aldrich) at −20 °C.
Paper Toxicology Research
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Total RNA was extracted from stored samples using the
trizol, chloroform, glycogen extraction method. Briefly, RNA
later was completely removed from samples and whole tissues
or cells were homogenised in trizol solution (1 ml, Sigma-
Aldrich) in RNase free microcentrifuge tubes (Axygen, Califor-
nia, USA). Following a 5 minute incubation at room tempera-
ture, chloroform (200 µl, Sigma-Aldrich) was added and after
vigorous shaking, the mixture was centrifuged (12 000g,
15 minutes, 4 °C). The upper aqueous phase (500 µl) of the bi-
phasic solution was transferred to a fresh microcentrifuge tube
and glycogen (10 µg, Fermentas, UK) was added. The aqueous
phase was mixed with 70% isopropanol (500 µl, Sigma-
Aldrich), incubated at room temperature for 10 minutes and
centrifuged (12 000g, 10 minutes, 4 °C). The resulting pellet
was washed with 75% ethanol (Fisher Scientific, Loughbo-
rough, UK), air dried for 10 minutes, re-suspended in RNase-
free water (50 µl, Qiagen, Crawley, UK) and incubated at 60 °C
for 15 minutes. RNA quality was assessed by agarose gel elec-
trophoresis and quantified by spectrophotometry using a
Nanodrop ND1000 (Thermo Scientific, LabTech, East Sussex,
UK) and DNA contamination was removed by treatment with a
genomic DNA-free treatment kit (Ambion, Austin, U.S.A.).
Storage of RNA was at −80 °C.
cDNA synthesis
Total RNA was used for first-strand cDNA synthesis using the
SuperScript II Reverse Transcriptase kit (Invitrogen, Paisley,
U.K.) in a thermocycler (Eppendorf Mastercycler Gradient;
Eppendorf, Cambridge, UK). The cDNA produced was quanti-
fied by spectrophotometry and stored at −20 °C.
Polymerase chain reaction (PCR)
cDNA was used as a template for PCR and used to validate the
sequence-specific primers (Alta Bioscience, Birmingham, U.K)
designed for target genes using Primer 3 software or as
described in the literature (see Table 1). Stock solutions
(10 μM) of each primer were prepared and 50 μl reactions
made using components of the DreamTaq DNA Polymerase
PCR kit (Fermentas, U.K.), in microcentrifuge tubes. DNA poly-
merase (1.25 units), forward and reverse primers (10 pmol
each), 2 mM dNTP mix (0.2 mM each), 10× DreamTaq buﬀer
(5 μl), template DNA (100 ng) and dH2O were combined to a
final volume of 50 μl. The PCR programme consisted of an
initial 5 minute denaturation period at 95 °C, 35 cycles of
denaturation at 95 °C for 1 minute, 1 minute annealing
periods at the required primer annealing temperature and
extension at 72 °C for 1 minute, followed by a final extension
step at 72 °C for 5 minutes in a thermocycler. The resulting
products were analysed by DNA gel electrophoresis and com-
parisons of fragment size were made using a 100 base pair
ladder (New England Biolabs, Ipswich, UK).
DNA sample purification and sequencing
PCR products were purified using QIAquick spin columns
(Qiagen Ltd, West Sussex, UK), according to the manufac-
Table 1 PCR primers and product sizes
Gene Primer sequence
Product
size (bp)
Primer
concentration (pM)
Calculated average
primer eﬃciency (%) References
CYP1A F: 5′-GAT GTC AGT GGC AGC TTT GA-3′ 104 2.0 101.6 N/A
R: 5′-TCC TGG TCA TCA TGG CTG TA-3′
CYP2K1 F: 5′-CTC ACA CCA CCA GCC GAG AT-3′ 164 1.5 97.9 78
R: 5′-CTT GAC AAA TCC TCC CTG CTC AT-3′
CYP2M1 F: 5′-GCT GTA TAT CAC ACT CAC CTG CTT TG-3′ 195 1.5 97.2 78
R: 5′-CCC CTA AGT GCT TTG CAT GTA TAG AT-3′
CYP3A27 F: 5′-GAC GGT GGA GAT CAA CG-3′ 240 1.0 96.2 79
R: 5′-GAG GAT CTC GAC CAT GG-3′
UGT F: 5′-ATA AGG ACC GTC CCA TCG AG-3′ 113 3.0 97.3 N/A
R: 5′-ATC CAG TTG AGG TCG TGA GC-3′
MDR1 F: 5′-GGA ACT GTC CTC ACC GTG TT-3′ 136 3.0 100.5 N/A
R: 5′-GGG GTT TAT TGT CGG TGA TG-3′
MRP2 F: 5′-CCA TTC TGT TCG CTG TCT CA-3′ 150 2.0 95.1 N/A
R: 5′-CTC GTA GCA GGG TCT GGA AG-3′
BCRP F: 5′-AGG CCT GCT GGT GAA CCT G-3′ 101 4.0 95.8 46
R: 5′-ACT CAT TAA TTT GGA GAG CTG TTA GTC C-3′
BSEP F: 5′-CCG ACC AGG GCA AAG TGA TT-3′ 101 1.5 98.6 N/A
R: 5′-CAG AAT GGG CTC CTG GGA TAC-3′
18S rRNA F: 5-TGG AGC CTG CGG CTT AAT TT-3′ 170 2.0 97.4 46
R: 5′-ATG CCG GAG TTT CGT TCG TT-3′
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turer’s protocol. Following elution, DNA was quantified by
spectrophotometry.
Purified DNA samples were then sequenced using an
ABI3730 DNA analyser (Applied Biosystems, UK) by the Func-
tional Genomics and Proteomics Unit, University of Birming-
ham, Birmingham, UK. The sequencing results of the
amplified DNA fragments obtained were used in BLAST
searches (www.ncbi.nlm.nih.gov/blast) to confirm that the
primers amplified the selected genes of interest.
Real-time PCR
Real-time PCR was conducted using an ABI Prism 7000
Sequence Detection System (Applied Biosystems, USA). cDNA
prepared from RNA extracted from various tissue and cell
samples were used as the template for reactions with the Sensi-
Fast SYBR Hi-Rox kit (Bioline, UK). Five biological replicates
were used for each of the target genes, with each individual
assessed in triplicate. Samples were run in 96 well plates, each
sample containing cDNA (90 ng), 2× sensiFast SYBR (10 μl)
using forward and reverse primers at various concentrations (a
range of 1–5 pM) dependant on primer eﬃciency values calcu-
lated during optimisation runs, and nuclease free water in a
final volume of 20 μl. PCR cycle parameters were: 95 °C, 30
seconds for denaturation; and 60 °C, 30 seconds for combined
annealing and extension. No-template controls were also run
using sterile dH2O.
Melt curves for all samples were plotted and analysed using
the ABI Prism 7000 SDS software to ensure only a single
product was amplified and primer dimers were not formed.
PCR primer eﬃciencies were calculated using absolute fluo-
rescence values measured in each well and the LinRegPCR
software as described by ref. 54, as there can be a significant
eﬀect on fold diﬀerence calculations using Ct values calculated
from primers with unequal PCR eﬃciencies. Threshold cycle
(Ct) values were recorded for each sample in the linear phase
of amplification. Diﬀerences in Ct values were assessed by one
way ANOVA (SPSS v16.0).
Assays of uptake and elimination of fluorescent probes
To assess the role of transporters through the use of inhibitors,
the accumulation of fluorescent compounds known to be sub-
strates of particular drug eﬄux transporters (see Table 2) was
assessed following pre-incubations with specific transporter
inhibitors. Substrates and inhibitors were dissolved in various
solvents as noted and appropriate vehicle controls were used
for each. Hepatocyte spheroids were washed twice in PBS and
re-suspended in PBS. Inhibitors at a range of concentrations
(detailed in Table 3) were added to cultures and incubated for
10 minutes on a gyratory shaker at 50 rpm, following which,
the appropriate volume of fluorescent substrate was added to
reach the desired concentration. Total solvent concentrations
did not exceed 0.5% (v/v) and appropriate solvent controls
were always used. Spheroids were incubated in the dark, at
17 °C, on a gyratory platform at 50 rpm, for 60 minutes. After
incubation, cells were kept on ice, washed three times in PBS,
re-suspended and lysed in 0.1% Triton X-100 in PBS using an
ultrasonic water bath (Camlab Transsonic T460, Cambridge,
UK) in the dark. Lysate was loaded onto fluorescence 96 well
plates (BD Falcon) and fluorescence measured at the relevant
wavelength for each substrate (Table 2) using a Bio-Tek FL600
fluorescence plate reader. Fluorescent dye accumulation was
measured and compared to control cells exposed to the relevant
fluorescent substrate in the absence of the specific inhibitor.
Confocal microscopy
Cells exposed to various fluorescent compounds were washed
in PBS and re-suspended in phenol red free PBS. Suspended
cells were pipetted into glass bottom culture dishes (MatTek
Corporation, Massachusetts, USA) for imaging. Images were
acquired using a Leica TCS SP2 confocal microscope (Leica
Microsystems, Milton Keynes, UK) with a 63× oil immersion
objective lens. Fluorochromes were excited using an argon
laser at the wavelengths described previously.
Statistical analysis
Statistical analysis was conducted using SPSS version 16.0.
Tests for normality and homogeneity of variance were con-
ducted using the Shapiro Wilk and Levene’s tests respectively.
Data meeting the assumption criteria for parametric tests were
analysed using the Independent samples T-test and data not
meeting these criteria were analysed using the Kruskal-Wallis
and Mann-Whitney U test (non parametric). P values <0.05
were deemed significant.
Table 3 Speciﬁc inhibitors used in eﬄux transporter inhibition studies
Eﬄux
transporter Inhibitor
Concentration
range (µM)
Solvent
(maximum
concentration)
MDR1 Cyclosporine A 0.01–20 DMSO (0.1%)
MRP2 Probenecid 0.5–1000 NaOH (0.01%)
BCRP Sodium taurocholate 1–1500 Sterile dH2O
BSEP Ko 143 0.01–20 DMSO (0.4%)
Table 2 Fluorescent compounds used in spheroid uptake and elimination studies
Fluorescent compound
Eﬄux
transporter
Concentration
(μM)
Solvent (maximum
concentration)
Fluorescence
wavelengths
Calcein AM MRP2 10 DMSO (0.4%) λex: 494 nm; λem 517 nm
Cholyl-lysyl-fluorescein BSEP 5 Sterile dH2O λex: 485 nm; λem 520 nm
2′,7′-Dichlorodihydrofluorescein diacetate BSEP 10 DMSO (0.05%) λex: 495 nm; λem 530 nm
Hoechst 33342 BCRP 10 Sterile dH2O λex: 340 nm; λem 510 nm
Rhodamine 123 MDR1 10 DMSO (0.05%) λex: 511 nm; λem 534 nm
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Results
Investigations were conducted on hepatic preparations derived
from the same subset of fish. Gene expression analyses were
conducted on cells isolated from the same five individual fish
and functional transporter assays using specific inhibition
were conducted using three individual fish. The confocal
images provided are representative.
To provide a temporal overview of the changes in gene
expression during the various stages in spheroid development,
expression data is presented in the form of heat maps display-
ing the range of expression levels of each gene, recorded in
each of the types of hepatocyte preparation. Values recorded
are cycle threshold (Ct) values, which display an inverse
relationship to the amount of nucleic acid measured in
samples, representing absolute expression. Therefore, the
lowest extreme Ct values, represent the highest level of
expression. The scale bars above the maps indicate the range
of recorded Ct values (from lowest to highest).
Status of eﬄux transporter gene expression in hepatocyte
preparations
Diﬀerences in transcript levels of the transporters of interest
(MDR1, BSEP, MRP2 and BCRP) were seen in the diﬀerent hep-
atocyte cultures assessed (freshly isolated suspensions, mono-
layer cultures 24 and 48 hours post isolation and spheroid
cultures 5, 7, 10, 15 and 25 days post isolation) (Fig. 1).
Expression levels of BSEP and BCRP in monolayer culture were
lower than those measured in freshly isolated hepatocytes and,
following a recovery in early spheroid culture, an increase in
expression was evident in mature spheroids.
In conventional monolayer culture, there was a decline in
the expression of both BSEP and BCRP at 24 and 48 hours post
isolation, when compared to the level measured in freshly iso-
lated hepatocytes. This was seen by an increase in Ct value and
a corresponding fold change of 0.55 ± 0.18 (p < 0.05, Mann-
Whitney U test) and 0.63 ± 0.13 (p < 0.05, Mann-Whitney
U test) for BSEP and BCRP respectively in monolayer culture
24 hours post isolation and 0.51 ± 0.20 (p < 0.05, Mann-
Whitney U test) and 0.79 ± 0.13 (p > 0.05, Mann-Whitney
U test) respectively in monolayer culture 48 hours post iso-
lation (Fig. 1). In contrast to these declines, increases in the
expression of MRP2 and MDR1, relative to levels measured in
freshly isolated hepatocytes, were measured in monolayer cul-
tures at the same time points. MRP2 expression in hepatocytes
48 hours post isolation exhibited a significant fold change of
2.07 ± 0.44 (p < 0.05, Mann-Whitney U test) in comparison to
freshly isolated hepatocytes and there were also significant
fold changes of 1.52 ± 0.25 and 2.09 ± 0.49 (p < 0.05, Mann-
Whitney U test) in the expression of MDR1 in monolayer cul-
tures 24 hours and 48 hours post isolation respectively, when
compared to freshly isolated hepatocytes (Fig. 1).
Eﬄux transporter expression levels measured in hepato-
cytes in spheroid culture were greater than, or equal to, levels
measured in conventional primary hepatocyte cultures. During
the development of spheroid structures (between 5–10 days
post isolation), expression of genes for eﬄux transporters
remained relatively stable (with the exception of BCRP
expression in spheroids 10 days post isolation) although,
gradual increases in the expression of MRP2 and MDR1 were
seen. This increase in MRP2 expression in early spheroids,
continued at subsequent time points. The highest levels of
expression of all eﬄux transporters were measured in mature
spheroids, with significant increases in the expression of
MRP2 and MDR1 (7.88 ± 1.02 and 2.59 ± 0.28 fold respectively)
recorded in spheroids 25 days post isolation.
In all hepatocyte preparations and at all time points, BSEP
was the eﬄux transporter exhibiting the greatest level of
expression (Fig. 1). This observation was in accordance with
the expression of BSEP in whole liver samples taken from the
same individual fish and in accord with published data.34 In
contrast, MRP2 exhibited the lowest level of expression in
freshly isolated hepatocytes and hepatocytes in monolayer
culture (comparable to the expression in whole liver) and the
level of MDR1 expression was lowest in hepatocyte spheroids
compared to other preparations at all time points. The pattern
of expression of the transporters of interest was constant at all
stages of spheroid culture.
Functional activity of eﬄux transporters in spheroid
hepatocytes
The functions of the eﬄux transporters of interest were
assessed using fluorescent substrates and inhibitors success-
fully employed in other studies (e.g. ref. 29, 32, 46, 49 and 55).
The fluorescent substrates used were calcein-acetoxymethyles-
ter (Ca-AM), rhodamine 123 (Rh123), hoechst 33342 (H33342)
and 2′,7′-dichlorodihydrofluorescein diacetate (DHFDA). The
Fig. 1 Expression levels of genes related to ABC eﬄux transporters in
freshly isolated hepatocytes, hepatocytes in monolayer culture (24 and
48 hours post isolation) and hepatocyte spheroids. The bar above the
heat map indicates the scale of Ct values measured in cell samples with
red representing the lowest extreme Ct value, therefore the greatest
level of expression; blue representing the highest extreme Ct value,
therefore the lowest level of expression; and black representing the
median level of expression (n = 5 ﬁsh).
Toxicology Research Paper
This journal is © The Royal Society of Chemistry 2015 Toxicol. Res., 2015, 4, 494–507 | 499
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
9 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 0
2/
07
/2
01
5 
14
:4
2:
09
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
intracellular presence and accumulation of these compounds
in spheroids was observed and confirmed by confocal
microscopy (Fig. 2). Increases in intracellular accumulation of
substrates as a result of specific inhibition were quantified
using a fluorescence plate reader and compared to the fluo-
rescence measurements recorded in control cells. All inhibi-
tors investigated caused significant changes in substrate
accumulation.
The highest maximal fluorescence accumulation in spher-
oids was seen with sodium taurocholate, used to inhibit BSEP.
A 3.70 fold increase in DHFDA accumulation was measured at
1.0 and 1.5 mM concentrations of sodium taurocholate. Inhi-
bition of DHFDA eﬄux was not significant below concen-
trations of 500 µM (Fig. 3A). In comparison, fluorescence
accumulation as a result of BCRP inhibition by Ko143 was con-
siderably lower, with a maximum 1.38 fold increase in H33342
accumulation. BCRP inhibition by Ko143 caused significant
increases in fluorescence at concentrations of 2 µM and above
(p < 0.05, Mann-Whitney U test) however, a distinct concen-
tration-dependent increase of H33342 was not evident as a
result of BCRP inhibition (Fig. 3B).
In contrast, inhibition of MDR1 activity was seen at cyclo-
sporin A concentrations of 10 and 20 µM with concentration-
dependent increase in intracellular rhodamine 123 accumu-
lation of 1.5 fold and 1.8 fold respectively (Fig. 3C). Probenecid
produced concentration-dependent increases of calcein-AM
accumulation, through the inhibition of MRP2 in spheroids
(Fig. 3D). A significant increase in fluorescence accumulation
(p < 0.05, individual samples T test) was measured in cells
exposed to concentrations of 100 µM and above, with a
maximum 2.95 fold accumulation measured at 1 mM.
Re-formation of bile canaliculi in spheroid hepatocytes
The fluorescent bile acid cholyl-lysyl-fluorescein (CLF) was
found to be taken up into spheroids and subsequently released
with time. Spheroids were treated with fluorescent CLF and
allowed to eﬄux the marker over a period of 30 minutes,
revealing some evidence of the concentration of pools of punc-
tate fluorescence, which did not correspond to the structure of
whole cells (Fig. 4). It is possible that this punctate labelling is
reflective of the presence of canalicular structures from which
bile release from spheroids is mediated.
Changes in the expression of genes involved in xenobiotic
metabolism in diﬀerent hepatocyte preparations
The transcript levels of CYP1A, CYP2K1, CYP2M1, CYP3A27
and UGT were also assessed and compared in the same hep-
atocyte preparations as used in transporter assessments. A
number of gene specific changes in expression levels in
diﬀerent hepatocyte preparations were identified (Fig. 5). A
decline in the expression of UGT, CYP2K1 and CYP2M1 was
evident in early monolayer culture, followed by a recovery in
late monolayer culture and early stages of spheroid culture.
Expression levels of CYP1A and CYP3A27 gradually increased
in this timeframe; with a sharp decline in CYP1A expression
evident in spheroids 5 days post isolation. Levels of expression
of the genes of interest appeared to be relatively more stable in
more mature spheroids (Fig. 5).
With the exception of CYP1A and CYP3A27, the expression
levels of all genes in monolayer culture 24 hours post isolation
were less than, or equal to, those measured in freshly isolated
hepatocytes. However, in monolayer cultures 48 hours post
Fig. 2 Representative visualisation of the accumulation of DHFDA (A), H33342 (B), calcein-AM (C) and rhodamine 123 (D) in hepatocytes in spheroid
cultures. A–D 1 show representative controls and A–D 2 show representative spheroids following treatment with sodium taurocholate (A), Ko143 (B),
probenecid (C) and cyclosporin A (D). The intracellular accumulation of ﬂuorescent probes in spheroids was observed using confocal microscopy. At
the maximum concentrations of inhibitors used, a greater accumulation of ﬂuorescence was observed in spheroids, in comparison to untreated cells
in each case. Spheroids used from 15 days post isolation. Images from left to right: ﬂuorescence channel; Bright ﬁeld scan; merged image. All scale
bars indicate 100 µm.
Paper Toxicology Research
500 | Toxicol. Res., 2015, 4, 494–507 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
9 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 0
2/
07
/2
01
5 
14
:4
2:
09
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
isolation, expression increased to a level greater than that
measured in freshly isolated hepatocytes (with the exception of
UGT expression). In the majority of cases, expression levels
measured in hepatocyte spheroids were greater than measured
in freshly isolated hepatocytes and hepatocytes in monolayer
culture. The expression of CYP1A was the exception to this,
with the level of expression lower at all stages of spheroid
maturation, than measured in monolayer culture and less
than, or equal to, the level recorded in freshly isolated hepato-
cytes. Experience in our laboratory has also demonstrated
diﬃculty in replicating in vivo activity of CYP1A (via EROD)
using primary monolayer cultures.56
In spheroid culture, expression levels of genes related to
xenobiotic metabolism were generally highest at 5 and 7 days
post isolation, with a small decline at 10 and 15 days post iso-
lation; with the exception of CYP1A and CYP3A27 at 10 days
post isolation and CYP1A in spheroids 15 days post isolation.
However, expression levels remained greater than that
Fig. 4 Confocal imaging of cholyl-lysyl-ﬂuorescein (CLF) distribution
within spheroids. Spheroids were treated with CLF for 30 minutes and
images show evidence of the concentration of the ﬂuorescent com-
pound in these structures. Staining was punctate and did not corres-
pond to a pan-cellular localisation within individual cells. This may
reﬂect the presence, in part, of canalicular structures between cells
from which bile release from hepatocyte spheroids is mediated. Spher-
oids used from 15 days post isolation. Images from left to right: ﬂuor-
escence channel; Bright ﬁeld scan; merged image. All scale bars indicate
100 µm.
Fig. 5 Relative expression levels of genes related to xenobiotic meta-
bolism in freshly isolated hepatocytes, hepatocytes in monolayer culture
(24 and 48 hours post isolation) and hepatocyte spheroids. The bar
above the heat map indicates the scale of Ct values measured in cell
samples with red representing the lowest extreme Ct value, therefore
the greatest level of expression; blue representing the highest extreme
Ct value, therefore the lowest level of expression; and black representing
the median level of expression.
Fig. 3 The eﬀect of sodium taurocholate (A), Ko143 (B), probenecid (C) and cyclosporin A (D) on the accumulation of the substrates shown in each
case within hepatocyte spheroid cultures. Data represent mean ﬂuorescence accumulation relative to uninhibited controls and expressed as a per-
centage increase ±SEM. Control ﬂuorescence accumulation = 100%; *p < 0.05 (signiﬁcantly greater than control), Mann-Whitney U test (n = 3 ﬁsh).
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measured in freshly isolated hepatocytes. Gene expression
later increased at 25 days post isolation (with the exception of
CYP1A), to levels greater than measured at 10 days post iso-
lation and less than but closer in comparison to those detected
at 5 and 7 days post isolation. Mature spheroids (10, 15 and 25
days post isolation) appeared to retain the most similar
pattern of expression in comparison to that observed in the
whole liver (Fig. 5). However, caution must be exercised when
making such comparisons as a smaller proportion of hepato-
cytes (in the region of 80%), contribute to the total liver
protein in whole liver.
Principal component analyses
The principal component analysis plot (Fig. 6) demonstrates
the overall predominant similarity of spheroids to whole liver
with respect to drug eﬄux transporters.
Discussion
The transport of compounds through cell membranes is an
important feature of xenobiotic detoxification, having a key
influence on the absorption, distribution, elimination, toxicity
and eﬃcacy of compounds. For the majority of compounds,
transport and metabolism must be assessed together to allow
accurate predictions of in vivo disposition, physiological eﬀects
and xenobiotic fate to be made.2,57 Importantly, this feature is
lacking in assays currently used for the assessment of the
bioaccumulation potential of environmental contaminants,
conducted using subcellular fractions, where the cellular
uptake and elimination of a xenobiotic is assumed.58 The aim
of the present investigation was to explore the potential advan-
tages of the use of hepatocyte spheroids (pertaining to the
greater expression and activity of drug transporters), making
such assays more informative, with respect to the evaluation of
bioaccumulation potential and therefore more relevant to the
detoxification of compounds in vivo.
In this study, the expression and activity of all of the eﬄux
transporters of interest was identified in hepatocyte spheroids
at diﬀerent stages of maturity. Although some variation in
expression levels was evident at diﬀerent time points, tran-
script levels were generally greater than those measured in
conventional cultures. A general down-regulation of expression
in monolayer culture was evident, most likely to be associated
with cellular de-diﬀerentiation in these cultures. Following a
recovery period in early spheroid culture, an increase in the
expression of genes related to xenobiotic metabolism and
transport was evident in mature spheroids, reaching the
highest values in aggregates 25 days post isolation.
The 3D structure of hepatocytes, with enhanced cell–cell
and cell-extracellular matrix interactions is thought to be
responsible for the restoration and maintenance of cellular
polarisation and diﬀerentiation, lost during the isolation
process and in conventional culture.17,59 De-diﬀerentiation
and the ensuing loss of gene expression and specific cellular
functions has traditionally been problematic in conventional
cultures.2 Cellular diﬀerentiation is known to be mediated
through extracellular signals via locally acting molecules
within the extracellular matrix and from adjacent cells. These
interactions directly aﬀect cell function and behaviour, regu-
lated at gene expression level.60 The importance of diﬀeren-
tiation status on the expression of the uptake transporter
organic anion transporter polypeptide (OATP) and the eﬄux
transporter MRP1 has previously been shown in trout cell
lines.34,61 Therefore, maintenance of cellular diﬀerentiation as
seen in spheroid hepatocytes, confers significant advantages,
making this model an attractive alternative for in vitro studies
of drug transporters.
In common with expression in whole liver samples, in all
in vitro preparations and at all time points in culture, the
expression of BSEP was the greatest of all transporters investi-
gated. This is in accordance with a study in which BSEP
expression in trout liver tissue was measured as 750 fold and
114 fold greater than MDR1 and MRP2 respectively.29 High
hepatic BSEP expression is also a common feature measured
in mammalian systems, however in contrast, expression of the
transporter in a study using a variety of trout cell lines (includ-
ing 3 of hepatic origin) was among the lowest of those investi-
gated.46 In addition, no functional activity of BSEP or BCRP
was identified in trout hepatocyte-derived cell lines, despite
being the highest expressed transporters in vivo. This is a key
issue for these cell lines and has significant implications for
using that model in examining xenobiotic metabolism and
Fig. 6 Principal components analysis (PCA) scores plot for the proﬁle
of expression of genes related to xenobiotic eﬄux in whole liver and all
hepatocyte preparations. The plot shows separation of in vivo and
in vitro preparations along the PC2 and PC3 axes. There was a clear sep-
aration of hepatocytes in monolayer culture at the greatest extreme
(bottom left quadrant) from the whole liver sample. In comparison, the
expression proﬁle of freshly isolated hepatocytes was closer to that of
the whole liver than to the other conventional cell culture types. Varia-
bility existed in the expression proﬁle of spheroid hepatocytes according
to stage of culture, however, spheroids at all time points displayed a
better resemblance to the expression proﬁle of the whole liver. Spheroid
hepatocytes 5, 7 and 25 days post isolation showed the best similarity to
the expression proﬁle in vivo. FIH: freshly isolated hepatocytes; H24:
monolayer culture 24 hpi; H48: monolayer culture 48 hpi; S5: spheroid
culture 5 dpi; S7: spheroid culture 7 dpi; S10: spheroid culture 10 dpi;
S15: spheroid culture 15 dpi; S25: spheroid culture 25 dpi.
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transport. BSEP is involved in the eﬄux of a wide range of
endogenous and exogenous compounds, with a particular role
in the secretion of bile acids into the bile canaliculus.34,62 The
lack of OATP which imports bile acids into hepatocytes and
the absence of a canalicular structure has been suggested as a
cause for the low expression and lack of BSEP function in trout
cell lines.46,63 Rat hepatocyte couplets exhibit bile canalicular
structures into which bile constituents are secreted64,65 indi-
cating the importance of cell–cell structural interactions. In
the current investigation, it was observed that hepatocytes con-
nected via spheroid structure retain BSEP expression and func-
tion and there is some evidence of canalicular structure
(Fig. 4), similar to structures observed in rat hepatocyte spher-
oids.6 The uptake and release of CLF, occurred in trout spher-
oids where release was inhibited by sodium taurocholate. The
concentration of punctate fluorescent staining which did not
correspond to the structure of whole cells suggested the pres-
ence of functional canalicular structures (Fig. 4). These find-
ings again present advantageous features of spheroids for use
in studies of xenobiotic transport compared to the use of hep-
atocyte derived cell lines lacking such structures.
Similar to the expression of genes related to transport,
expression of genes related to xenobiotic metabolism were
generally greater in spheroids than in freshly isolated hepato-
cytes or in monolayer culture. With the exception of CYP1A,
expression levels in spheroids did not fall below those
measured in other hepatocyte preparations.
Temporal diﬀerences were evident in the profile of
expression of all genes (both metabolism and transport
related) in hepatocyte spheroids, with cells 10 days post iso-
lation showing the greatest deviation with respect to the in vivo
profile and spheroids 25 days post isolation demonstrating the
greatest analogy. In this study, the point at which little to no
change in microscopic structural arrangements were seen was
used as the indicator of morphological maturation. At this
stage, spheroids exhibited a more homogeneous shape than
those of earlier time points. It may be possible that this
marker of morphological maturation does not necessarily
match a similar period of gene expression, where levels are
expected to stabilise. It has been reported that in rat hepato-
cyte spheroids, biochemical and functional turbulence occurs
as spheroids mature in early culture, recovering and stabilising
after about 6 days.17 The expression profile of spheroids in this
study at 10 days post isolation was markedly diﬀerent from
that of other spheroids. The temporal and transient decline in
gene expression measured at this stage may be reflective of a
similar period of turbulence and instability. Indeed, changes
in cellular protein content, increases in levels of albumin syn-
thesis and changes in metabolism, to levels more reflective of
those measured in intact tissue has been reported during the
transition from immature to mature spheroids.14 The exact
stage at which gene expression stabilises in trout hepatocyte
spheroids may be later than that of the observed morphologi-
cal maturation, potentially explaining the expression diﬀer-
ences observed at 10 days post isolation. It remains unclear
however, exactly at which stage trout hepatocytes can be noted
as mature and it has been suggested that despite classifying
spheroids as mature after a period of 6–8 days, the fusion of
cells may continue up to 16 days.14 Functional stability may
prove to be a better indicator of maturity for use of spheroids
in specific assays. Also, xenobiotic metabolism activities in rat
hepatocyte spheroids remained significantly higher than in rat
hepatocyte monolayer cultures.4
It is diﬃcult to directly compare expression levels between
isolated hepatocyte preparations and whole liver due to diﬀer-
ences in cellular composition. Hepatocytes have been shown
to be quantitatively dominant in trout liver, contributing
around 80–85% liver volume.66,67 Whole liver samples include
at least 10 other, non-parenchymal cell types68 which play a
role in the function, diﬀerentiation and gene regulation of
hepatocytes, through inter-cellular signalling.69,70 It has been
reported that co-culture systems maintaining parenchymal and
non-parenchymal cells concurrently, show improved morpho-
logical characteristics and increased drug metabolism
capabilities71–73 and this could be applied to trout hepatocyte
spheroids in the future. Despite this, hepatocyte spheroids
retained a more representative profile of gene expression
related to the xenobiotic detoxification process than the mono-
layer cultures.
To assess functionality of the transporter proteins encoded
by the genes of interest in spheroid cultures, transporter activi-
ties were investigated using specific fluorescent substrates and
inhibitors used in mammalian eﬄux transporter assays, many
of which have been used in previous studies involving fish
in vitro hepatic preparations.32,46,55 Significant diﬀerences in
the accumulation of substrates were seen in spheroids at the
highest inhibitory concentrations of all compounds used,
suggesting that the transporters of interest identified in spher-
oids were functional and susceptible to inhibition. In common
with the high expression of BSEP in spheroids, its inhibition
resulted in the greatest substrate accumulation. High levels of
DHFDA accumulation in spheroids was in agreement with the
inhibition of BSEP in trout hepatocyte monolayer cultures,29
highlighting the potential importance of biliary excretion path-
ways in rainbow trout, as demonstrated by the detection of
xenobiotics and metabolites in bile collected from whole
fish.74
A lack of knowledge of the exact specificities of inhibitors
and the broad and overlapping substrate specificities of eﬄux
transporters proves problematic in the accuracy of functional
transporter assays. Especially for the assessment of transpor-
ters in fish as the assumption of activities is based on the
mammalian literature. Recent studies have highlighted the
relatedness of MDR1, BSEP and MRP-group transporters,
raising questions on the inhibitory specificity of cyclosporin A
and the transporter specificities of rhodamine 123 and
calcein-Am among others.29,32,46,75 An important feature to
explore further in hepatocyte spheroids is the use of transpor-
ter inhibitor co-exposure, to block multiple eﬄux pathways, to
circumvent the lack of knowledge of transporter substrate
specificity. The expression of individual transporters could
also be down-regulated using RNAi, however problems with
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transfection eﬃciency in primary cells, especially those of
piscine origin, have been reported.76,77 It may also be possible
that inhibition of individual transporters can result in the up-
regulation of other, closely related transporters, with overlap-
ping specificity. Nevertheless, irrespective of the precise speci-
ficity of inhibitors, it is clear that transporter eﬄux was
measurable and susceptible to inhibition (Fig. 3).
A number of environmentally relevant compounds have
been shown to modify the expression and function of eﬄux
transporters in aquatic organisms as well as genes involved in
xenobiotic metabolism.20,36,46 Both may contribute to the
accumulation of compounds in organisms when exposed to
mixtures of environmental contaminants.32,47 As a result,
information on the eﬄux of compounds and their potential to
inhibit transporter function should be included in the assess-
ment of environmental contaminants. In this study, emphasis
has been placed on the eﬄux of compounds. However, in the
prediction of the potential of a compound to bioaccumulate,
the kinetics of uptake, influenced by factors such as lipid solu-
bility and intestinal transporter activity should also be con-
sidered in association with xenobiotic metabolic capacity
analysis. Information gained experimentally in this area could
be used to develop further predictive models that might
support the environmental risk assessment of xenobiotics and
industrial chemicals.
This study is the first to assess trout ABC transporters in
long term culture, showing the improved expression of the key
eﬄux transporters, in comparison to other cell culture models.
The spheroidal system has the potential to be adapted for
routine use in the assessment of environmental contaminants
as this would not only confer advantages of longevity and
maintained metabolic activity, but will also enable the incor-
poration of measurements of eﬄux and inhibition, aﬃrming
such cultures as a much more informative model for the
screening of bioaccumulation potential. The system will be of
high interest in the context of potential industrial use in a
range of in vitro metabolic and transport assessments of
chemical safety (especially with respect to assessments of
chronic exposure) and overcomes the de-diﬀerentiation associ-
ated with more conventional hepatocyte cultures that has
plagued researchers for many years.
Liver tissues used in this study were derived from freshly
euthanised rainbow trout supplied from stocks at the Univer-
sity of Birmingham. These stock fish were held with per-
mission from the UK Home Oﬃce under the Animals
(Scientific Procedures) Act 1986 and therefore under authoris-
ation by the University Ethics Committee. Since they were
killed under a schedule 1 method, they did not undergo a
scientific procedure by definition of the Act. This study com-
plied with regulatory and ethical standards in the UK and the
global ethical standards required by the industrial partner
AstraZeneca. One of the principle aims of this work was to
establish and characterise an in vitro model that will poten-
tially reduce the numbers of fish used in future environmental
tests required by regulatory authorities. Currently approxi-
mately 30 000 fish are used per year in the UK alone, more in
other countries; and these tests are required by regulatory
authorities around the world (see https://www.gov.uk/govern-
ment/publications/user-guide-to-home-oﬃce-statistics-of-scien-
tific-procedures-on-living-animals). By developing these in vitro
organoid models, we hope to contribute to reducing these
numbers in the future. Furthermore, since the fish used in
this study are not exposed to chemicals whilst alive, this rep-
resents a significant refinement in the methodology, and likely
reduces the eﬀects of endogenous stress responses. This study
represents a significant step towards developing future models
that will be acceptable to regulatory authorities, and therefore
is a key contribution towards our endeavours to further the
3Rs (Reduction, Refinement, Replacement) of vertebrate
animals in toxicology.
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